In vitro diagnosis (IVD) accounts for about 11% of the medical device industry, and is an important segment of medical devices, with an industry growth rate of about 18%. Due to the rapid development of technologies such as biotechnology and optoelectronics in my country, the innovation of in vitro diagnostic technology is very active and is favored by the primary and secondary capital markets.
In vitro diagnostic products are divided into in vitro diagnostic instruments and in vitro diagnostic reagents. According to the classification of diagnostic methods and objects, in vitro diagnostic instruments can be divided into clinical chemical analysis instruments, immunochemical analysis instruments, blood analysis instruments and microbiological analysis instruments, etc. According to the method of matching reagents, in vitro diagnostic equipment can be divided into open systems and closed systems two categories. There is no professional restriction between the detection reagents and equipment used in the open system, so the same system is suitable for reagents from different manufacturers, while the closed system usually requires exclusive reagents to complete the test successfully. At present, the world’s major in vitro diagnostic manufacturers mainly focus on closed systems. On the one hand, there are certain technical barriers between different diagnostic (test) methods, and on the other hand, closed systems have good continuous profitability.
According to the detection principle and detection method, in vitro diagnostic reagents can be divided into biochemical diagnostic reagents, immunodiagnostic reagents, molecular diagnostic reagents, microbial diagnostic reagents, urine diagnostic reagents, coagulation diagnostic reagents, hematology and flow cytometry diagnostic reagents, etc.
In vitro diagnosis (IVD) refers to a diagnostic method that removes samples (blood, body fluids, tissues, etc.) from the human body for detection to determine diseases or bodily functions, involving molecular biology, genetic diagnosis, translational medicine and other disciplines. According to estimates, the global in vitro diagnostic market in 2018 was about US$68 billion, a year-on-year increase of 4.62%. It is predicted that the annual growth rate of 3-5% will be maintained in the next ten years. Among them, immunodiagnosis has become the most important segment.
Post time: Mar-22-2022